CONCENTRA GROUP HOLDINGS PARENT, INC. vs FRESENIUS MEDICAL CARE AG, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CON and FMS diverge most: on debt / equity, CON reads 3.62 and FMS reads 0.00; on revenue growth, CON reads +15.5% and FMS reads +1.5%. The rest of the comparable metrics sit closer together. What FMS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CON | FMS |
|---|---|---|
| Price | $31.65 | $25.66 |
| Market cap | $4.1B | $15.0B |
| Sector | Medical Care | Medical Care |
| Stage | Growth | Mature |
| Implied growth (priced in) | -1.6% | — |
| P/E | 22.8 | 14.1 |
| P/B | 9.41 | 0.97 |
| P/S | 1.82 | 0.70 |
| EV/EBITDA | 13.0 | 3.7 |
| Revenue growth | +15.5% | +1.5% |
| Operating margin | 16.8% | 11.7% |
| Net margin | 8.0% | 6.1% |
| Return on equity | 41.2% | 8.3% |
| Return on assets | 6.2% | 3.8% |
| Return on invested capital | 13.2% | 10.1% |
| FCF yield | 5.2% | 19.4% |
| Dividend yield | 0.8% | 1.6% |
| Debt / equity | 3.62 | 0.00 |
| Current ratio | 1.26 | 1.26 |
| Altman Z (solvency) | 2.01 | 1.81 |
| Piotroski F (quality) | 7 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.